The contracting future with AI, FAR/DFARS regulatory updates, and the applicability of federal requirements on nonprofits, state, and local governments are a few trending topics that LBG’s Dan Vest looks …
Clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of laboratory medicine are just a few key topics of discussion at the 2023 AACC Annual Scientific …
Robert Huebner, Ph.D. was recently appointed to the Missouri Biotechnology Association (MOBIO) Board of Directors. The MOBIO Board of Directors assists and helps guide MOBIO leadership by promoting the enrichment …
LBG was recently awarded a grant by the Bill & Melinda Gates Foundation to develop an easy-to-use, web-based modeling tool for use in determining the cost of goods of pharmaceutical …
Written by LBG’s Lauren Schoukroun-Barnes, Ph.D., Dianne Cantara, Sarah DeDonder, Ph.D., and Dawn Speidel, “Pharmaceutical Manufacturing Quality Assurance Programs: Transitioning from Research and Development to the Clinic” was recently published in BioProcess International. The article …
Therapeutic frontiers, the business of biotech, regulatory and policy outlooks, and human capital are just a few of the trending topics of discussion at the BIO International Convention. LBG Partners …
The record number of gene, gene-modified cell therapies since last year and the recent approval of Gamida Cell’s Omisirge off-the-shelf allogeneic therapy raises an important question: How are other advanced …
Quality oversight, regulatory perspective, and risk management in the changing vendor quality landscape are key topics of discussion at the FDA-NJPQCA Conference on May 23 in Kenilworth, New Jersey. The theme …
Co-authored by Thijs Beuming, Ph.D., “Are Deep Learning Structural Models Sufficiently Accurate for Virtual Screening? Application of Docking Algorithms to AlphaFold2 Predicted Structures” was recently published in the Journal of …
Written by Robert Huebner, Ph.D., “Leveraging modernization of the US influenza vaccine manufacturing base to make better vaccines: a work in progress” was recently published in Vaccine Insights. Dr. Huebner …